BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16416440)

  • 1. Magnetic resonance imaging of myocardial infarction using a manganese-based contrast agent (EVP 1001-1): preliminary results in a dog model.
    Storey P; Chen Q; Li W; Seoane PR; Harnish PP; Fogelson L; Harris KR; Prasad PV
    J Magn Reson Imaging; 2006 Feb; 23(2):228-34. PubMed ID: 16416440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.
    Ruzsics B; Surányi P; Kiss P; Brott BC; Elgavish A; Simor T; Elgavish GA
    J Magn Reson Imaging; 2008 Dec; 28(6):1386-92. PubMed ID: 19025946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assessment of left-ventricular infarction size, function and tissue viability in a murine model of myocardial infarction by cardiac manganese-enhanced magnetic resonance imaging (MEMRI).
    Hu TC; Bao W; Lenhard SC; Schaeffer TR; Yue TL; Willette RN; Jucker BM
    NMR Biomed; 2004 Dec; 17(8):620-6. PubMed ID: 15761951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart.
    Storey P; Danias PG; Post M; Li W; Seoane PR; Harnish PP; Edelman RR; Prasad PV
    Invest Radiol; 2003 Oct; 38(10):642-52. PubMed ID: 14501492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.
    Bremerich J; Saeed M; Arheden H; Higgins CB; Wendland MF
    Radiology; 2000 Aug; 216(2):524-30. PubMed ID: 10924581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
    Zuo CS; Seoane P; Lanigan T; Harnish P; Prasad PV; Storey P; Li W; Rofsky NM
    J Magn Reson Imaging; 2002 Dec; 16(6):668-75. PubMed ID: 12451580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging.
    Jacquier A; Boussel L; Amabile N; Bartoli JM; Douek P; Moulin G; Paganelli F; Saeed M; Revel D; Croisille P
    Invest Radiol; 2008 Nov; 43(11):773-81. PubMed ID: 18923256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.
    Flacke S; Allen JS; Chia JM; Wible JH; Periasamy MP; Adams MD; Adzamli IK; Lorenz CH
    Radiology; 2003 Mar; 226(3):731-8. PubMed ID: 12601183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution.
    Surányi P; Kiss P; Brott BC; Simor T; Elgavish A; Ruzsics B; Saab-Ismail NH; Elgavish GA
    Magn Reson Med; 2006 Sep; 56(3):535-45. PubMed ID: 16892184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
    Klumpp B; Fenchel M; Hoevelborn T; Helber U; Scheule A; Claussen C; Miller S
    Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of acute myocardial infarction using a nitroxyl spin label (PCA).
    McNamara MT; Wesbey GE; Brasch RC; Sievers R; Lipton MJ; Higgins CB
    Invest Radiol; 1985 Sep; 20(6):591-5. PubMed ID: 4066230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
    Skjold A; Amundsen BH; Wiseth R; Støylen A; Haraldseth O; Larsson HB; Jynge P
    J Magn Reson Imaging; 2007 Sep; 26(3):720-7. PubMed ID: 17729351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring dynamic alterations in calcium homeostasis by T (1)-weighted and T (1)-mapping cardiac manganese-enhanced MRI in a murine myocardial infarction model.
    Waghorn B; Edwards T; Yang Y; Chuang KH; Yanasak N; Hu TC
    NMR Biomed; 2008 Nov; 21(10):1102-11. PubMed ID: 18780285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct extent by MRI correlates with peak serum troponin level in the canine model.
    Gallegos RP; Swingen C; Xu XJ; Wang X; Bianco R; Jerosch-Herold M; Bolman RM
    J Surg Res; 2004 Aug; 120(2):266-71. PubMed ID: 15234222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement.
    Wagner A; Mahrholdt H; Thomson L; Hager S; Meinhardt G; Rehwald W; Parker M; Shah D; Sechtem U; Kim RJ; Judd RM
    J Am Coll Cardiol; 2006 May; 47(10):2027-33. PubMed ID: 16697321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of MRI to differentiate between temporary and long-term coronary artery occlusion in a minimally invasive model of experimental myocardial infarction.
    Abegunewardene N; Vosseler M; Gori T; Hoffmann N; Schmidt KH; Becker D; Kreitner KF; Petersen SE; Schreiber LM; Horstick G; Münzel T
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1033-41. PubMed ID: 19472001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial viability in a reperfused porcine model: evaluation of different MSCT contrast protocols in acute and subacute infarct stages in comparison with MRI.
    Brodoefel H; Reimann A; Klumpp B; Fenchel M; Ohmer M; Miller S; Schroeder S; Claussen C; Scheule A; Kopp AF
    J Comput Assist Tomogr; 2007; 31(2):290-8. PubMed ID: 17414768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.
    Ibrahim T; Bülow HP; Hackl T; Hörnke M; Nekolla SG; Breuer M; Schömig A; Schwaiger M
    J Am Coll Cardiol; 2007 Jan; 49(2):208-16. PubMed ID: 17222732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.